"Camden Clark Medical Center serves the Mid-Ohio Valley and surrounding region through a 302-bed, not-for-profit, acute care facility. We provide a broad range of services, offering the latest in medical technology and a highly trained staff. As the DSC_0234fwcommunity’s hospital for more than a century, Camden Clark maintains a leadership role as the region’s primary source for advanced health care and wellness programs and has earned accreditation from The Joint Commission. Our Vision: Camden Clark Medical Center will be the leading regional medical center, known for high quality, comprehensive, state-of-the-art healthcare. Our Mission: To meet the healthcare needs of our community for a lifetime."

During the past decade, Camden Clark Medical Center conducted 60 clinical trials. In the 10-year time frame, 60 clinical trials started and 29 clinical trials were completed, i.e. on average, 48.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 21 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Camden Clark Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 41 trials, followed by "SWOG Cancer Research Network" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "NSABP Foundation Inc" with 9 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Camden Clark Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 51 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "Eastern Cooperative Oncology Group" with 5 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Camden Clark Medical Center" are "Breast Cancer" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (4 trials) and "Stage IIB Breast Cancer AJCC v6 and v7" (4 trials). Many other conditions were trialed in "Camden Clark Medical Center" in a lesser frequency.

Most popular intervention types in "Camden Clark Medical Center" are "Drug" (76 trials), "Other" (63 trials), "Biological" (43 trials), "Procedure" (26 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (36 trials), "Quality-of-Life Assessment" (28 trials), "Computed Tomography" (14 trials), "Nivolumab" (13 trials) and "Questionnaire Administration" (12 trials). Other intervention names were less common.

The vast majority of trials in "Camden Clark Medical Center" are 75 trials for "All" genders, 19 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Camden Clark Medical Center". undefined are not yet recruiting, 22 are recruiting, 40 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Camden Clark Medical Center, 3 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Camden Clark Medical Center, 1 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 66 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".